Feed Conversion Ratio (FCR) and Performance Group Estimation Based on Predicted Feed Intake for the Optimisation of Beef Production.

This paper reports on the use of estimates of individual animal feed intake (made using time spent feeding measurements) to predict the Feed Conversion Ratio (FCR), a measure of the amount of feed consumed to produce 1 kg of body mass, for an individual animal. Reported research to date has evaluated the ability of statistical methods to predict daily feed intake based on measurements of time spent feeding measured using electronic feeding systems. The study collated data of the time spent eating for 80 beef animals over a 56-day period as the basis for the prediction of feed intake. A Support Vector Regression (SVR) model was trained to predict feed intake and the performance of the approach was quantified. Here, feed intake predictions are used to estimate individual FCR and use this information to categorise animals into three groups based on the estimated Feed Conversion Ratio value. Results provide evidence of the feasibility of utilising the 'time spent eating' data to estimate feed intake and in turn Feed Conversion Ratio (FCR), the latter providing insights that guide farmer decisions on the optimisation of production costs.

Brain exposure of the ATM inhibitor AZD1390 in humans-a positron emission tomography study.

BACKGROUND: The protein kinase ataxia telangiectasia mutated (ATM) mediates cellular response to DNA damage induced by radiation. ATM inhibition decreases DNA damage repair in tumor cells and affects tumor growth. AZD1390 is a novel, highly potent, selective ATM inhibitor designed to cross the blood-brain barrier (BBB) and currently evaluated with radiotherapy in a phase I study in patients with brain malignancies. In the present study, PET was used to measure brain exposure of 11C-labeled AZD1390 after intravenous (i.v.) bolus administration in healthy subjects with an intact BBB. METHODS: AZD1390 was radiolabeled with carbon-11 and a microdose (mean injected mass 1.21 µg) was injected in 8 male subjects (21-65 y). The radioactivity concentration of [11C]AZD1390 in brain was measured using a high-resolution PET system. Radioactivity in arterial blood was measured to obtain a metabolite corrected arterial input function for quantitative image analysis. Participants were monitored by laboratory examinations, vital signs, electrocardiogram, adverse events. RESULTS: The brain radioactivity concentration of [11C]AZD1390 was 0.64 SUV (standard uptake value) and reached maximum 1.00% of injected dose at Tmax[brain] of 21 min (time of maximum brain radioactivity concentration) after i.v. injection. The whole brain total distribution volume was 5.20 mL*cm-3. No adverse events related to [11C]AZD1390 were reported. CONCLUSIONS: This study demonstrates that [11C]AZD1390 crosses the intact BBB and supports development of AZD1390 for the treatment of glioblastoma multiforme or other brain malignancies. Moreover, it illustrates the potential of PET microdosing in predicting and guiding dose range and schedule for subsequent clinical studies.

Identification of the Rumination in Cattle Using Support Vector Machines with Motion-Sensitive Bolus Sensors.

The reticuloruminal function is central to the digestive efficiency in ruminants. For cattle, collar- and ear tag-based accelerometer monitors have been developed to assess the time spent ruminating on an individual animal. Cattle that are ill feed less and so ruminate less, thus, the estimation of the time spent ruminating provides insights into the health of individual animals. pH boluses directly provide information on the reticuloruminal function within the rumen and extended (three hours or more) periods during which the ruminal pH value remains below 5.6 is an indicator that dysfunction and poor welfare are likely. Accelerometers, incorporated into the pH boluses, have been used to indicate changes in behaviour patterns (high/low activity), utilised to detect the onset of oestrus. The paper demonstrates for the first time that by processing the reticuloruminal motion, it is possible to recover rumination periods. Reticuloruminal motion energy and the time between reticuloruminal contractions are used as inputs to a Support Vector Machine (SVM) to identify rumination periods with an overall accuracy of 86.1%, corroborated by neck mounted rumination collars.

Is there a preference for PET or SPECT brain imaging in diagnosing dementia? The views of people with dementia, carers, and healthy controls.

BACKGROUND: Positron emission tomography (PET) and single photon emission computed tomography (SPECT) brain imaging are widely used as diagnostic tools for suspected dementia but no studies have directly compared participant views of the two procedures. We used a range of methods to explore preferences for PET and SPECT. METHODS: Patients and controls (and accompanying carers) completed questionnaires immediately after undergoing PET and SPECT brain scans. Pulse rate data were collected during each scan. Scan attributes were prioritized using a card sorting exercise; carers and controls additionally answered willingness to pay (WTP) questions. RESULTS: Few differences were found either between the scans or groups of participants, although carers marginally preferred SPECT. Diagnostic accuracy was prioritized over other scan characteristics. Mean heart rate during both scans was lower than baseline heart rate measured at home (p < 0.001). CONCLUSION: Most participants viewed PET and SPECT scans as roughly equivalent and did not have a preference for either scan. Carer preference for SPECT is likely to reflect their desire to be with the patient (routine practice for SPECT but not for PET), suggesting that they should be able to accompany vulnerable patients throughout imaging procedures wherever possible. Pulse rate data indicated that brain imaging was no more stressful than a home visit (HV) from a researcher. The data do not support the anecdotal view that PET is a more burdensome procedure and the use of PET or SPECT scans in dementia should be based on diagnostic accuracy of the technique.

Multivariate modelling to study the effect of the manufacturing process on the complete tablet dissolution profile.

Dissolution is invariably identified as a critical quality attribute for oral solid dosage forms, since it is related to when a drug is available for absorption and ultimately exert its effect. In this paper, the influence of granule and compression variability introduced by a design of experiments on the entire dissolution profile was studied with an innovative multivariate tool: bi-directional projections to orthogonal structures (O2PLS). This method enabled a more holistic process understanding compared to conventional approaches where only a single response is used to quantify dissolution. The O2PLS analysis of tablet manufacturing data showed that the disintegration phase of dissolution (10-15 min) was controlled by granule attributes and tablet hardness, while the later phase (15-30 min) was solely controlled by granule attributes. The bidirectional nature of the O2PLS model made it more fit for exploratory purposes, but decreased predictive ability. This approach does not require prior knowledge on the dissolution mechanism and is therefore particularly suited for exploratory studies gaining process understanding during early phase development. The outcome can then guide the selection of attributes, parameters and their ranges for the development of predictive models, e.g., models to define a suitable design space for the process.

Clinical utility of ultra high pitch dual source thoracic CT imaging of acute pulmonary embolism in the emergency department: are we one step closer towards a non-gated triple rule out?

OBJECTIVES/PURPOSE: Aim of this study was to retrospectively compare the image quality and the radiation dose of an ultra high pitch CT scan for the evaluation of pulmonary embolism and visualization of cardiac structures in comparison to our institution's standard pulmonary embolism protocol. METHOD AND MATERIALS: The study cohort consisted of 115 consecutive patients, 57 underwent CT pulmonary angiography on a dual source 128 slice scanner (Siemens Somatom Definition FLASH) via an ultra high pitch mode (Pitch 2.8) while 58 were scanned on a dual source 64 slice scanner (Siemens Somatom Definition Dual Source) with standard pitch (Pitch 0.9). Qualitative image assessment was determined by two blinded radiologists with 3 and 15 years' experience in chest and cardiac CT. Quantitative image assessment was determined by the signal to noise ratio (SNR) and contrast to noise ratio (CNR). Effective radiation dose was calculated via the product of the dose length product. RESULTS: For the ultra high pitch protocol, 14% (8/57) were positive for pulmonary embolus compared to 13.7% (8/58) for the standard pitch group. 98.2% of the ultra high pitch scans were diagnostic for pulmonary embolus vs. 94.8% of the standard protocol. Visualization of cardiac structures was significantly improved with the ultra high pitch protocol (p<0.0001). Significantly more lung parenchymal motion was observed on the standard protocol (p<0.0001). The mean pulmonary vessel attenuation, SNR, and CNR were not significantly different. The mean effective dose was lower for the ultra high pitch studies (4.09mSv±0.78 vs. 7.72mSv±2.60, p<0.0001). CONCLUSION: Ultra high pitch CT imaging for pulmonary embolus is a technique which has potential to assess motion free evaluation of most cardiac structures and proximal coronary arteries at lower radiation doses.

Organ-based computed tomographic (CT) radiation dose reduction to the lenses: impact on image quality for CT of the head.

PURPOSE: Recently, a new specific organ dose adaption and reduction protocol, or SODAR tool (X-CARE, Siemens Healthcare), which reduces dose to the anterior aspect of the body of patients, was installed on our computed tomographic scanner. The purpose of this pilot project was to evaluate image quality and dose distribution in the acquired data with the new protocol. MATERIALS AND METHODS: Sixteen consecutive patients were scanned with the new SODAR head protocol. The findings were compared with 16 matched patients who were imaged with the standard computed tomographic head trauma protocol. Image quality was assessed qualitatively using a scale of 1 to 4 (1, excellent; 2, good; 3, fair; 4, nondiagnostic). Additionally, 1-cm regions of interest were placed in the white matter of the cerebral hemispheres, the cerebellar hemispheres, and the brain stem at the level of the pons for a quantitative analysis. The standard deviation of each measurement was recorded as an indicator for image noise. Dose measurement trials were performed using optically stimulated luminescence dosimeters on head phantoms and then on patients. RESULTS: Subjective image quality ranged between 1 and 3; no scan areas were considered nondiagnostic. Overall image quality of the posterior fossa averaged at 1.656 was slightly reduced compared to the cerebral hemispheres (mean, 1.141). The mean standard protocol brain stem image quality was 1.604, with only minimal deterioration to 1.708 in the SODAR group.No significant difference in image noise could be found between the SODAR group with a mean noise of 4.515 and standard images with a mean of 4.721 (P > 0.05).The dose to the anterior aspect of the patient was lowered to 3.2 mGy compared to 4.5 mGy on the lateral aspect of the scan (P > 0.05). To compensate for the photon loss in the posterior aspect, the dose has to be slightly increased to a mean of 6 mGy, but overall, a significant dose reduction with stable image quality could be achieved by reducing the dose length product from 1489 to 1347 mGy·cm using SODAR (P < 0.0001). CONCLUSION: Using the SODAR protocol resulted not only in an impressive 46% to 59% frontal dose reduction but also in the overall dose reduction. This dose reduction was obtained without sacrificing image quality, providing diagnostic images of the brain while protecting radiosensitive structures like the eye lenses in trauma brain imaging. Future applications will be reducing dose to other radiosensitive structures such as the thyroid gland and breast tissue from potentially harmful low-energy radiation without compromising image quality.

Qualitative beta-hCG urine assays may be misleading in the presence of molar pregnancy: a case report.

Molar pregnancy is a rare complication of pregnancy and the diagnosis is usually confirmed with a markedly elevated beta-hCG and a "snowstorm" appearance on pelvic ultrasound. Patients frequently present with a positive pregnancy test, vaginal bleeding, nausea and vomiting. A 23-year-old woman presented to our Emergency Department with a history of 7 weeks of intermittent vaginal bleeding and 1 h of peri-umbilical abdominal pain. She reported that 7 weeks before this visit she was diagnosed with a miscarriage. The bedside qualitative urine human chorionic gonadotropin (hCG) test that we performed was negative, but the quantitative serum hCG was markedly elevated. Ultrasound and operative findings confirmed the diagnosis of molar pregnancy. We conclude that rapid urine qualitative hCG assays may not be reliable in the presence of markedly elevated hCG levels found in molar pregnancy.